Health Canada grants licence for Medtronic’s renal denervation system
The Symplicity Spyral system is designed for patients whose blood pressure remains high despite medication.
20 March 2024
20 March 2024
The Symplicity Spyral system is designed for patients whose blood pressure remains high despite medication.
US private equity company GTCR will now control Cloudbreak.
Clinical evaluations have highlighted the impact of the technology, indicating a possible reduction in VT procedure times.
The technology streams visual and audio instructions as the user interacts with the dialysis machine.
The trial data will support the US marketing authorisation of Nyxoah’s Genio hypoglossal nerve stimulation system for treating obstructive sleep apnoea.
Coming ahead of a planned pre-market approval to the FDA, the topline results found that Cerus’ blood system saw only a 2.5% rate of adverse events.
The financing round was led by Galaxy Sirius Partners and Johnson & Johnson Innovation.
The deal comes after Titan Medical announced in 2023 that it was shutting down its research and development division to focus purely on marketing pre-existing devices.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.